Jasmine M. Chaitram, 1,2 * Laura A. Jevitt, 1,2 Sara Lary, 1,2 Fred C. Tenover, 1,2 and The WHO Antimicrobial Resistance Group 3,4

Size: px
Start display at page:

Download "Jasmine M. Chaitram, 1,2 * Laura A. Jevitt, 1,2 Sara Lary, 1,2 Fred C. Tenover, 1,2 and The WHO Antimicrobial Resistance Group 3,4"

Transcription

1 JOURNAL OF CLINICAL MICROBIOLOGY, June 2003, p Vol. 41, No /03/$ DOI: /JCM The World Health Organization s External Quality Assurance System Proficiency Testing Program Has Improved the Accuracy of Antimicrobial Susceptibility Testing and Reporting among Participating Laboratories Using NCCLS Methods Jasmine M. Chaitram, 1,2 * Laura A. Jevitt, 1,2 Sara Lary, 1,2 Fred C. Tenover, 1,2 and The WHO Antimicrobial Resistance Group 3,4 Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, 1 and World Health Organization Collaborating Center for Global Antimicrobial Resistance Monitoring, 2 Atlanta, Georgia 30333; World Health Organization, Geneva, Switzerland 3 ; and World Health Organization Collaborating Center for Surveillance of Antimicrobial Resistance, Brigham and Women s Hospital, Boston, Massachusetts Received 19 December 2002/Returned for modification 27 January 2003/Accepted 25 March 2003 A total of 150 laboratories in 33 countries that followed the NCCLS testing procedures participated in the World Health Organization s External Quality Assurance System for Antimicrobial Susceptibility Testing (EQAS-AST) from January 1998 through March Laboratories tested seven bacterial isolates for antimicrobial resistance and reported the results to the Centers for Disease Control and Prevention (CDC) in Atlanta, Ga. The results were compared to the results generated at the CDC with the NCCLS broth microdilution and disk diffusion reference methods. Although there were few testing errors with Salmonella enterica subsp. enterica serovar Enteritidis, drugs that are not appropriate for therapy of Salmonella infections were tested and reported by 136 (91%) of 150 laboratories. In addition, 29 (20%) of 150 laboratories used the Staphylococcus aureus breakpoints to report oxacillin results for Staphylococcus saprophyticus. For a vanbcontaining Enterococcus faecalis strain, 124 (83%) of 150 laboratories correctly reported vancomycin results that were 1 doubling dilution from the reference MIC or 3 mm from the reference disk diffusion result. Of the laboratories that tested Streptococcus agalactiae by disk diffusion, 17% reported nonsusceptible results for penicillin in error. While 110 laboratories (73%) tested the S. pneumoniae challenge isolate against a fluoroquinolone, 83% tested it against ciprofloxacin, for which there are no NCCLS interpretive criteria. Ten of 12 laboratories testing levofloxacin and 4 of 4 laboratories testing ofloxacin by an MIC method correctly reported resistant results for the isolate. Feedback letters sent to participating laboratories highlighted areas of susceptibility testing in individual laboratories that needed improvement. The positive impact of the feedback letters and the overall effectiveness of the EQAS program were documented in repeat testing challenges with pneumococci and staphylococci. The 31 and 19% increases in the numbers of laboratories using appropriate testing methods for pneumococci and staphylococci, respectively, in 2000 versus 1998 indicate that laboratory performance is improving. Clinical microbiology laboratories, through routine antimicrobial susceptibility testing and participation in various surveillance programs, help monitor the development and spread of antimicrobial resistance in their communities. The accuracy of data generated by both formal and informal surveillance systems has been debated for several years, which has led to a call for more careful monitoring of laboratory performance through external quality assurance and proficiency testing programs (12, 15). Proficiency testing is an external quality assurance method in which laboratories are sent simulated clinical specimens or bacterial isolates for testing by routine laboratory methods. Proficiency testing provides data about the accuracy of susceptibility testing and can determine if a laboratory s * Corresponding author. Mailing address: Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, 1600 Clifton Rd., MS G-08, Atlanta, GA Phone: (404) Fax: (404) zoa6@cdc.gov. The members of the WHO Antimicrobial Resistance Group are Rosamund Williams, Philip Jenkins, John Stelling, and Thomas O Brien. methods are sufficiently sensitive to detect novel resistance patterns. This method of quality assurance also allows a clinical laboratory s performance to be assessed in comparison to reference methods and to other peer laboratories. Several reports suggest that providing feedback on proficiency testing results improves the quality of testing among clinical laboratories (7, 8, 17). A previous report on the External Quality Assurance System for Antimicrobial Susceptibility Testing (EQAS-AST), coordinated by the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC), highlighted the types of testing errors that were common among participating laboratories (15). The goals of the present study were (i) to determine if laboratories are following the NCCLS guidelines for reporting results for salmonellae and coagulase-negative staphylococci (CoNS); (ii) to assess the accuracy with which laboratories test and report results for group B streptococci, vanb-containing enterococci, and fluoroquinolone-resistant pneumococci; and (iii) to determine if feedback letters with specific recommendations for modifying susceptibility 2372

2 VOL. 41, 2003 ANTIMICROBIAL SUSCEPTIBILITY PROFICIENCY TESTING 2373 TABLE 1. Antimicrobial agents tested and reported for S. enterica subsp. enterica serovar Enteritidis a Antimicrobial agent(s) testing strategies improve the performance of laboratories when they are rechallenged with similar organisms. MATERIALS AND METHODS No. of laboratories reporting results for each antimicrobial agent (%) Recommended Ampicillin (94) Chloramphenicol (78) Fluoroquinolones (87) Trimethoprim-sulfamethoxazole (91) Expanded-spectram cephalosporins (91) Inappropriate Aminoglycosides (80) Aztreonam (65) Imipenem (79) Piperacillin (75) Narrow- and improved-spectram cephalosporins (42) a Not all of the laboratories tested all of the antimicrobial agents listed. Distribution. The following organisms were sent to approximately 300 laboratories outside of the United States: vancomycin-intermediate Staphylococcus epidermidis and penicillin-susceptible Streptococcus pneumoniae in 1998, vanbcontaining Enterococcus faecalis and fluoroquinolone-resistant S. pneumoniae in 1999, ampicillin- and tetracycline-resistant Salmonella enterica subsp. enterica serovar Enteritidis and penicillin-susceptible S. pneumoniae in 2000 (the same isolate that was sent in 1998), Staphylococcus saprophyticus (a CoNS), a group B beta-hemolytic streptococcus, and vancomycin-intermediate S. epidermidis in 2001 (the same isolate that was sent in 1998). Coordinating centers were established in Argentina, Bulgaria, China, Colombia, Croatia, the Czech Republic, Finland, Korea, Japan, and Saudi Arabia to facilitate the distribution of organisms and reporting of results. Testing. Participants were instructed to test the organisms only once with their standard testing method. Laboratories were directed to process the isolate as if it had been obtained from a positive blood culture. For each organism, a data collection sheet was provided that solicited information on the antimicrobial susceptibility testing method used (MIC or disk diffusion), sources of media and reagents, interpretive criteria used (e.g., NCCLS [9 11], the Comité de l Antibiogramme de la Société de Française Microbiologie [5], or the British Society for Antimicrobial Chemotherapy [18, 19]), and disk potency. The data sheets included a suggested set of antimicrobial agents to test and provided space to fill in additional drugs that were tested in the laboratory. Laboratories were asked to provide both quantitative results (MICs or zone diameters) and the qualitative interpretations (i.e., susceptible, intermediate, or resistant) for each antimicrobial agent tested. Some laboratories reported using WHONET software as the source of their interpretative criteria (14). The organisms were tested TABLE 3. Interpretative errors for testing of S. saprophyticus Test result 3 reference result a (error type) multiple times at the CDC by broth microdilution (BMD) and disk diffusion by NCCLS methods (9 11) to establish the reference MIC and disk diffusion values. The MIC testing methods reported by participating laboratories included Etest, Microscan, Vitek, and Sensititre; however, the methods and media used were not consistently reported. Data analysis. Data sheets were returned by the individual laboratories or the coordinating centers to the CDC within 2 months of receipt of the proficiency test organisms. The data were entered into an SAS data set (SAS, Cary, N.C.). The data set for this report includes results from 150 laboratories representing 33 countries that use NCCLS methods. Calculated mean values were rounded to the nearest whole number. Feedback and follow-up. Feedback letters describing the resistance patterns of the challenge organisms and summarizing the results from individual laboratories in comparison to all other laboratories were sent to the individual laboratories or to the coordinating centers for distribution to their participants. In addition, we conducted an anonymous survey of participants to determine the usefulness of the EQAS-AST proficiency testing program. RESULTS No. of laboratories Erythromycin Oxacillin Penicillin S 3 R (very major) R 3 S (major) S 3 I (minor) I 3 S (minor) R 3 I (minor) I 3 R (minor) Total a S, susceptible; I, intermediate. R, resistant. Reporting of challenges. One hundred fifty participants reported results for an S. enterica subsp. enterica serovar Enteritidis isolate that was resistant to ampicillin and tetracycline but susceptible to chloramphenicol, ciprofloxacin, and trimethoprim-sulfamethoxazole. Of the 150 laboratories, 26% used an MIC method and 74% used disk diffusion. Only one laboratory reported a susceptible result for ampicillin, and another reported a susceptible result for tetracycline. However, 136 laboratories (91%) tested and reported agents other than those recommended by the NCCLS for Salmonella infections, such as gentamicin, narrow- and improved-spectrum cephalosporins, and imipenem (Table 1). No laboratories reported false resistance to fluoroquinolones. Of 150 laboratories, 139 (93%) were able to identify the staphylococcal challenge organism as a CoNS, 3 (2%) identi- Antimicrobial agent BMD ( g/ml) Reference result (category) c DD a (mm) TABLE 2. Results for S. saprophyticus No. of laboratories reporting results Correct results Interpreted correctly b BMD DD BMD DD Erythromycin 0.5 (S) 25 (S) (78) d 47 (47) 32 (100) 45 (96) Penicillin 0.5 (R) 22 (R) (46) 56 (57) 16 (100) 55 (98) Oxacillin 1.0 (R) 12 (R) (82) 66 (65) 19 (61) 49 (74) b Interpretation based on NCCLS criteria (11). c S, susceptible; R, resistant. d The values in parentheses are percentages of the total.

3 2374 CHAITRAM ET AL. J. CLIN. MICROBIOL. Antimicrobial agent (no. of laboratories) BMD ( g/ml) Reference result (category) c TABLE 4. Results for E. faecalis No. of laboratories reporting DD results (range in mm) c No. of laboratories reporting MIC results (range in g/ml) c DD (mm) a S I R S I R Ampicillin (146) 1 (S) 23 (S) 97 (19 33) 0 5 (6 15) 44 (0.19 8) 0 0 Penicillin (131) 4 (S) 17 (S) 85 (15 34) 0 8 (6 14) 38 ( ) 0 0 Teicoplanin (84) 0.5 (S) b 18 (S) b 52 (14 24) 3 (12 13) 0 29 ( ) 0 0 Vancomycin (149) 32 (R) 15 (I) 13 (17 23) 22 (15 16) 48 (6 14) 13 ( 0.5 4) 15 (8 16) 38 (32 256) b Consistent with a VanB phenotype. c S, susceptible; I, intermediate; R, resistant. fied the organism as S. aureus, and 8 (5%) did not report an identification. Of the 139 that identified the organism as a CoNS, 122 (88%) correctly identified the organism as S. saprophyticus. Of 140 laboratories that tested and reported results for oxacillin, 97 (70%) obtained the correct MIC within 1 doubling dilution of the reference MIC or the correct diameter within 3 mm of the reference disk diffusion result. Of those that obtained the correct results, 61% of the MICs and 74% of the disk diffusion results, respectively, were interpreted with the appropriate interpretative criteria for oxacillin (Table 2), i.e., those for CoNS. Nineteen laboratories (20%) reported this organism as oxacillin susceptible, resulting in 19 very major errors (11 obtained by the BMD or Etest method and 8 obtained by disk diffusion). In addition, 10 laboratories (10%) reported this organism as intermediate to oxacillin, resulting in 10 minor errors (1 obtained by an MIC method and 9 obtained by disk diffusion) (Table 3). Testing challenges. Laboratories were sent a vanb-containing E. faecalis isolate that was vancomycin resistant but penicillin and ampicillin susceptible. Five (3%) laboratories reported the organism as ampicillin resistant, and eight (6%) reported the organism as penicillin resistant; in addition, one laboratory reported a beta-lactamase-positive result, which was incorrect (Table 4). Seventy-four (89%) out of 83 laboratories correctly reported disk diffusion results within 3 mmofthe reference result. Forty-seven (71%) of 66 laboratories testing by an MIC method reported a result that was 1 doubling dilution of the CDC result. Of the 13 laboratories that reported vancomycin-susceptible results for the disk diffusion method, only two reported an unacceptably large zone diameter. The results for the S. pneumoniae challenge are shown in Table 5. This strain is susceptible to penicillin and cephalosporins but resistant to fluoroquinolones. Ninety-one of the 110 laboratories that tested a fluoroquinolone chose ciprofloxacin, for which there are no NCCLS interpretive criteria. The zone diameter results for ciprofloxacin ranged from no zone to 35 mm; with a mean of 15 mm. Ten of 12 laboratories that tested levofloxacin and all 4 of the laboratories testing ofloxacin reported resistant results consistent with the NCCLS interpretive criteria. The group B beta-hemolytic streptococcus (S. agalactiae) challenge strain was resistant to erythromycin and tetracycline but remained susceptible to penicillin, extended-spectrum cephalosporins, and clindamycin. It contains the mef(a) macrolide efflux gene, which mediates resistance to erythromycin but not clindamycin. Sixty percent of disk diffusion users reported this strain as erythromycin intermediate rather than resistant, which is consistent with the relatively low erythromycin MIC of 8 g/ml. The organism should be reported as clindamycin susceptible, although 10 laboratories, all disk diffusion users, reported intermediate or resistant results. Seven laboratories (7%) using disk diffusion reported this strain as penicillin resistant although the reference zone diameter result for penicillin was very large (30 mm). A total of 11 laboratories reported resistant disk diffusion results for cefotaxime and or ceftriaxone (Table 6). Repeat challenges to assess improvement in test selection. A pneumococcal isolate with reduced susceptibility to penicillin was sent in 1998 and again in 2000 and was tested both times by a subset of 52 laboratories. This organism produces a zone size of 13 to 15 mm around a 1- g oxacillin disk, indicating that a penicillin MIC test should be performed. In 1998, 32 (71%) out of 45 laboratories testing oxacillin reported a zone of 19 mm, while in 2000, 22 (69%) out of 32 testing oxacillin reported a zone diameter of 19 mm. Although the MIC of penicillin for this organism is typically in the susceptible range (modal MIC 0.06 g/ml), penicillin MICs as high as 0.5 g/ml, interpreted as intermediate, were reported by two laboratories in 2000 (Table 7). MIC results of g/ml were Antimicrobial agent (no. of laboratories) BMD ( g/ ml) TABLE 5. Results for S. pneumoniae No. of laboratories reporting DD results (range in mm) b No. of laboratories reporting MIC results (range in g/ml) b DD (mm) a S I R S I R Levofloxacin (12) 8 (R) 10 (R) 0 1 (14) 8 (6 12) 1 ( 0.5) 0 2 (8 16) Penicillin (107) 0.01 (S) 0 54 (52 45) 0 1 (12) 50 ( ) 1 (0.5) 1 (4)

4 VOL. 41, 2003 ANTIMICROBIAL SUSCEPTIBILITY PROFICIENCY TESTING 2375 TABLE 6. Results for S. agalactiae Antimicrobial agent (no. of laboratories) No. of laboratories reporting DD results (range in mm) b No. of laboratories reporting MIC results (range in g/ml) b BMD ( g/ml) DD (mm) a S I R S I R Cefotaxime (100) 0.03 (S) 30 (S) 74 (24 40) 0 5 (6 23) 21 ( ) 0 0 Ceftriaxone (86) 0.06 (S) 28 (S) 65 (25 40) 0 10 (8 22) 11 ( ) 0 0 Clindamycin (138) 0.25 (S) 21 (S) 89 (19 31) 8 (16 18) 2 (6 15) 39 ( ) 0 0 Erythromycin (142) 8 (R) 14 (R) 4 (21 25) 61 (16 20) 36 (6 15) 7 ( 0.25) 1 (0.5) 33 (1 8) Penicillin (145) 0.06 (S) 30 (S) 89 (24 38) 0 7 (6 21) 49 ( ) 0 0 considered errors. Eight laboratories used penicillin disks in 2000, compared to 10 laboratories in 1998, with only 2 laboratories making the same error twice. In 1998, 18 laboratories tested cefotaxime and/or ceftriaxone by disk diffusion although there are no interpretive criteria for penicillin and cephalosporin disks in the NCCLS guidelines for this organism. In 2000, the number dropped to 13 laboratories. In 1998, 18 (35%) of 52 laboratories reported oxacillin screen test results of 19 mm without follow-up MIC testing whereas that number dropped to 7 (13%) of 52 in Thus, 16 (31%) of 52 laboratories improved their testing methods for penicillin, cephalosporins, or both drug classes in Finally, this isolate is also erythromycin resistant. In 2000, no laboratories reported erythromycin-susceptible results, which is an improvement over 1998, when 10% of the laboratories reported the isolate as erythromycin susceptible. A glycopeptide-intermediate strain of S. epidermidis, previously sent in 1998, was sent to participants again in The vancomycin MIC for this organism was 8 g/ml, and the teicoplanin MIC was 16 g/ml (Table 8). Of the 52 laboratories that tested this organism in both 1998 and 2001, 12 changed their testing method for this isolate for vancomycin from disk diffusion to an MIC method in 2001, resulting in a 19% improvement in the results. Follow-up survey. Of 115 laboratories returning the survey, 107 (93%) received feedback letters from the CDC or their coordinating centers critiquing their results. Ninety-nine of those (93%) shared this information with laboratory staff. Thirty-four percent made changes to their method of testing on the basis of the CDC s, or their coordinating center s, recommendations. Six of seven responding coordinating centers will continue to distribute proficiency test strains and feedback of results to laboratories after the EQAS-AST program is completed. DISCUSSION In the past, proficiency testing programs for antimicrobial susceptibility testing have focused primarily on testing accuracy. However, equally important is assessment of reporting accuracy. Although there were few testing errors with the S. enterica subsp. enterica serovar Enteritidis and S. saprophyticus isolates, there were multiple reporting errors with these organisms. NCCLS guidelines state that certain antimicrobial agents should not be tested or reported for Salmonella species because they may give false-susceptible results. Nonetheless, 136 laboratories tested and reported antimicrobial agents that are inappropriate for Salmonella infections (Table 1). Although salmonellae are tested with the same set of disks or MIC panels used for other gram-negative enteric organisms, laboratories must ensure that only the appropriate antimicrobial agents are reported. Some antimicrobial agents, such as the aminoglycosides, are always inappropriate; on the other hand, extended-spectrum cephalosporins, such as cefotaxime and ceftriaxone, are appropriate to report for extraintestinal Salmonella infections. Thus, it is important to test and report these agents selectively. In 2000, NCCLS changed the oxacillin breakpoints for CoNS to 0.25 g/ml or 18 mm for susceptible and 0.5 g/ml and 17 mm for resistant (no intermediate disk breakpoint). These breakpoints correlate much better with the results of meca testing for most CoNS strains. The purpose of the S. saprophyticus challenge was to verify that laboratories are aware of this change. Since the S. saprophyticus challenge organism demonstrates an oxacillin MIC of 1 g/ml and a zone diameter much smaller than the breakpoint of 17 mm (the mean was 12 mm), it would be classified as resistant by the new NCCLS criteria, presuming that the organism was not isolated from urine. In most instances, S. saprophyticus is recovered from the urinary TABLE 7. Results for S. pneumoniae TABLE 8. Results for S. epidermidis Antimicrobial agent No. of laboratories reporting results b in: BMD ( g/ml) DD (mm) a S I R S I R Antimicrobial agent No. of laboratories reporting results b in: BMD ( g/ml) DD (mm) a S I R S I R Clindamycin 0.12 (S) 22 (S) Erythromycin 4 (R) 10 (R) Penicillin 0.06 (S) Oxacillin 16 (R) 6 (R) Teicoplanin 16 (I) 14 (S) Vancomycin 8 (I) 16 (S)

5 2376 CHAITRAM ET AL. J. CLIN. MICROBIOL. tract and, according to the NCCLS, does not require routine testing because these infections respond to antimicrobial agents commonly used to treat acute, uncomplicated urinary tract infections (e.g., nitrofurantoin, trimethoprim-sulfamethoxazole, or a fluoroquinolone) (11). Because 29 laboratories reported this organism as susceptible or intermediate to oxacillin, resulting in 19 very major errors and 10 minor errors, respectively, it is clear that many laboratories used the S. aureus breakpoints even when 88% of the laboratories correctly identified this organism as S. saprophyticus. The E. faecalis challenge strain was V583, the first vanbcontaining (low-level vancomycin resistance) strain reported from the United States. This strain typically yields vancomycin MIC and disk diffusion results in the intermediate range (13). Although the mean vancomycin MIC reported by participating laboratories was 64 g/ml (resistant), the disk diffusion mean was 14 mm (resistant). The NCCLS recommends incubating both MIC and disk diffusion tests for a full 24 h before reading and interpreting results and also recommends retesting of isolates that yield disk diffusion results in the intermediate range by an MIC method (9 11). The vancomycin zones for enterococci should be read with transmitted light instead of reflected light, and any isolates with haze or growth within the zone of inhibition should be considered resistant. Disk diffusion results for vancomycin for enterococci are usually more difficult to interpret than MIC results. It is possible that the teicoplaninsusceptible results typical of vanb-containing strains caused some laboratories to assume that borderline vancomycin-resistant results were in error. In retrospect, this organism would not have been a good choice for proficiency testing if only qualitative results were considered because the accuracy of the disk diffusion tests spans the interpretative categories of susceptible, intermediate, and resistant. However, when the accuracy of the results is assessed independently of the interpretation, only 10% of laboratories reported vancomycin MICs more than 1 doubling dilution from the reference value or disk diffusion results greater than 3 mm from the reference disk result. These data are encouraging since previous studies have documented the difficulties in detecting low-level vancomycin resistance (1, 4, 16). S. agalactiae is an unusual proficiency-testing organism, but given the increased emphasis on detecting this organism in pregnant women (2) and the concern over increasing macrolide resistance in group B streptococci, we decided to include it as one of our challenges. While the NCCLS has published disk diffusion breakpoints for beta-lactam drugs such as penicillin, cefotaxime, and ceftriaxone, these tests can be difficult to read. Seven laboratories reported false penicillin resistance obtained by disk diffusion, and one laboratory reported falseresistance obtained by an MIC method. To our surprise, 11 laboratories reported resistance to cefotaxime and/or ceftriaxone. Penicillin and cephalosporin resistance has not been reported in group B streptococci. Fluoroquinolone resistance is emerging in pneumococci in several countries (3, 6). Although there are no NCCLS breakpoints for ciprofloxacin for S. pneumoniae, 91 (61%) laboratories tested this antimicrobial agent and 79 (87%) of these laboratories reported an interpretation for ciprofloxacin for our pneumococcal challenge organism in The mean disk diffusion result was 15 mm, which was reported by 15 laboratories, and 13 (87%) of these laboratories interpreted this result as indicating resistance. Nine laboratories tested ciprofloxacin by an MIC method, and six of these laboratories reported interpretations, all indicating resistance. Twelve laboratories (8%) tested the S. pneumoniae challenge against levofloxacin; four tested ofloxacin and one tested trovafloxacin. Breakpoints have been established for the latter three antimicrobial agents. In 1998, participants were sent a pneumococcal isolate that was resistant to erythromycin but susceptible to chloramphenicol and beta-lactam drugs such as penicillin and cefotaxime. In addition, this pneumococcal isolate consistently gives an oxacillin zone diameter of 19 mm and so, according to NCCLS guidelines, the laboratory should perform an MIC test rather than report a result based on the oxacillin screen test alone. Participants were also challenged with an S. epidermidis isolate with reduced susceptibility to vancomycin. As noted previously, disk diffusion does not detect decreased susceptibility to glycopeptides in staphylococci (16); however, many laboratories continue to use disk diffusion to test staphylococci against glycopeptides. Although disk diffusion works well for most other drug classes, alternate testing methods for glycopeptides must be used. For laboratories that routinely use disk diffusion, the BHI vancomycin agar screen test, which was developed for enterococci, can be used to detect strains of staphylococci with reduced susceptibility to vancomycin and teicoplanin. Feedback letters were sent to participants in 1998 including recommendations to improve testing methods for the pneumococci and staphylococci. The same laboratories were challenged again with the pneumococcal and staphylococcal isolates 2 years later to assess whether laboratory performance had improved. In 1998, only 27 (52%) out of 52 laboratories tested the S. pneumoniae isolate correctly with an MIC method for penicillin, although 32 (71%) out of 45 reported an oxacillin zone diameter of 19 mm. This improved to 73% in 2000 with 38 out of 52 laboratories performing an MIC test for penicillin although only 22 (68%) out of 32 reported a zone diameter of 19 mm for oxacillin. There were more laboratories correctly using an MIC method for penicillin in 2000, although the number of laboratories accurately testing oxacillin did not significantly change. Moreover, only 10% of the laboratories in 1998 were able to detect reduced susceptibility to vancomycin in staphylococci; this improved to 29% in Only two laboratories reported using the BHI vancomycin agar screen test in 1998 and 2000, and these laboratories were not the same in each year. Although many laboratories continue to use incorrect testing methods (e.g., disk diffusion for testing of pneumococci with penicillin and for detection of reduced susceptibility to vancomycin in staphylococci), our results indicate that laboratory performance can be improved by proficiency tests, followed by feedback of results. In some cases, laboratories were aware of the correct testing methods (and noted this on their data collection sheets) but, because of financial limitations, were not able to use the appropriate test methods. The improved performance of the laboratories and positive survey responses support the belief that the EQAS-AST program has been very useful in identifying areas for improvement in susceptibility testing methods and, in some cases, has led to better laboratory performance.

6 VOL. 41, 2003 ANTIMICROBIAL SUSCEPTIBILITY PROFICIENCY TESTING 2377 ACKNOWLEDGMENTS We thank all WHO EQAS-AST participants for sending their results. We also thank the EQAS-AST coordinating centers, the WHO regional offices, and the CDC shipping department for distributing proficiency test organisms. Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services. REFERENCES 1. Alonso-Echanove, J., B. Robles, W. R. Jarvis, and The Spanish VRE Study Group Proficiency of clinical laboratories in Spain in detecting vancomycin-resistant Enterococcus spp. J. Clin. Microbiol. 37: Centers for Disease Control and Prevention Prevention of perinatal group B streptococcal disease, revised guidelines from CDC. Morb. Mortal. Wkly. Rep. 51: Chen, D. K., A. McGreer, J. C. de Azavedo, and D. E. Low Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. N. Engl. J. Med. 341: Cookson, S. T., H. Lopardo, M. Marin, R. Arduino, M. J. Rial, M. Altschuler, L. Galanternik, J. M. Swenson, F. C. Tenover, J. I. Tokars, and W. R. Jarvis An Argentine-United States study to determine the ability of clinical laboratories to detect antimicrobial-resistant enterococcus isolates. Diagn. Microbiol. Infect. Dis. 29: Goldstein, F., C. J. Soussy, and A. Thabaut Report of the Comité de l Antibiogramme de la Société Française de Microbiologie. Definition of the clinical antibacterial spectrum of activity. Clin. Microbiol. Infect. 2:S40 S Ho, P. L., R. W. H. Yung, D. N. C. Tsang, T. L. Que, M. Ho, W. H. Seto, T. K. Ng, W. C. Yam, and W. S. Wilson Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in J. Antimicrob Chemother. 48: Juniper, I. R Quality issues in proficiency testing. Accred. Qual. Assur. 4: King, A., and D. F. J. Brown Quality assurance of antimicrobial susceptibility testing by disk diffusion. J. Antimicrob. Chemother. 48(Suppl. S1): NCCLS Performance standards for antimicrobial disk susceptibility tests, 7th edition, vol. 20, no. 1. Approved standard M2-A7. NCCLS, Wayne, Pa. 10. NCCLS Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 5th edition, vol. 17, no. 2. Approved standard M7-A5. NCCLS, Wayne, Pa. 11. NCCLS Performance standards for antimicrobial susceptibility testing. Twelfth informational supplement M100-S10. NCCLS, Wayne, Pa. 12. Richet, H. M., J. M. Mohammed, L. C. McDonald, and W. R. Jarvis Building communication networks: international network for the study and prevention of emerging antimicrobial resistance. Emerg. Infect. Dis. 7: Sahm, D. F., J. Kissinger, M. S. Gilmore, P. R. Murray, R. Mulder, J. Solliday, and B. Clarke In vitro susceptibility studies of vancomycinresistant Enterococcus faecalis. Antimicrob. Agents Chemother. 33: Stelling, J. M., and T. F. O Brien Surveillance of antimicrobial resistance: the WHONET program. Clin. Infect. Dis. 24(Suppl. S1): Tenover, F. C., M. J. Mohammed, J. Stelling, T. O Brien, and R. Williams Ability of laboratories to detect emerging antimicrobial resistance: proficiency testing and quality control results from the World Health Organization s External Quality Assurance System for antimicrobial testing. J. Clin. Microbiol. 39: Tenover, F. C., M. V. Lancaster, B. C. Hill, C. D. Steward, S. A. Stocker, G. A. Hancock, C. M. O Hara, S. A. McAllister, N. C. Clark, and K. Hiramatsu Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides. J. Clin. Microbiol. 36: Wood, R., and M. Thompson Proficiency testing in analytical laboratories: how to make it work. Accred. Qual. Assur. 1: Working Party of the British Society for Antimicrobial Chemotherapy Breakpoints in-vitro antibiotic susceptibility testing. J. Antimicrob. Chemother. 21: Working Party of the British Society for Antimicrobial Chemotherapy Supplementary report on antibiotic sensitivity testing. J. Antimicrob. Chemother. 38: Downloaded from on October 12, 2018 by guest

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2. AND QUANTITATIVE PRECISION (SAMPLE UR-01, 2017) Background and Plan of Analysis Sample UR-01 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony

More information

Background and Plan of Analysis

Background and Plan of Analysis ENTEROCOCCI Background and Plan of Analysis UR-11 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony count, to perform the identification

More information

جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی

جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی ویرایش دوم بر اساس ed., 2017 CLSI M100 27 th تابستان ۶۹۳۱ تهیه

More information

Tel: Fax:

Tel: Fax: CONCISE COMMUNICATION Bactericidal activity and synergy studies of BAL,a novel pyrrolidinone--ylidenemethyl cephem,tested against streptococci, enterococci and methicillin-resistant staphylococci L. M.

More information

Annual Report: Table 1. Antimicrobial Susceptibility Results for 2,488 Isolates of S. pneumoniae Collected Nationally, 2005 MIC (µg/ml)

Annual Report: Table 1. Antimicrobial Susceptibility Results for 2,488 Isolates of S. pneumoniae Collected Nationally, 2005 MIC (µg/ml) Streptococcus pneumoniae Annual Report: 5 In 5, a total of, isolates of pneumococci were collected from 59 clinical microbiology laboratories across Canada. Of these, 733 (9.5%) were isolated from blood

More information

Understanding the Hospital Antibiogram

Understanding the Hospital Antibiogram Understanding the Hospital Antibiogram Sharon Erdman, PharmD Clinical Professor Purdue University College of Pharmacy Infectious Diseases Clinical Pharmacist Eskenazi Health 5 Understanding the Hospital

More information

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing These suggestions are intended to indicate minimum sets of agents to test routinely in a diagnostic laboratory

More information

January 2014 Vol. 34 No. 1

January 2014 Vol. 34 No. 1 January 2014 Vol. 34 No. 1. and Minimum Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) Broth dilution: cation-adjusted Mueller-Hinton

More information

The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards

The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards Janet A. Hindler, MCLS, MT(ASCP) UCLA Health System Los Angeles, California, USA jhindler@ucla.edu 1 Learning Objectives Describe information

More information

European Committee on Antimicrobial Susceptibility Testing

European Committee on Antimicrobial Susceptibility Testing European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control as recommended by EUCAST Version 5.0, valid from 015-01-09 This document should be cited as "The

More information

Performance Information. Vet use only

Performance Information. Vet use only Performance Information Vet use only Performance of plates read manually was measured in three sites. Each centre tested Enterobacteriaceae, streptococci, staphylococci and pseudomonas-like organisms.

More information

Educating Clinical and Public Health Laboratories About Antimicrobial Resistance Challenges

Educating Clinical and Public Health Laboratories About Antimicrobial Resistance Challenges Educating Clinical and Public Health Laboratories About Antimicrobial Resistance Challenges Janet Hindler, MCLS MT(ASCP) UCLA Medical Center jhindler@ucla.edu also working as a consultant with the Association

More information

European Committee on Antimicrobial Susceptibility Testing

European Committee on Antimicrobial Susceptibility Testing European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST Version 8.0, valid from 018-01-01

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author Quality Assurance of antimicrobial susceptibility testing Derek Brown EUCAST Scientific Secretary ESCMID Postgraduate Education Course, Linz, 17 September 2014 Quality Assurance The total process by which

More information

/01/$ DOI: /JCM Copyright 2001, American Society for Microbiology. All Rights Reserved.

/01/$ DOI: /JCM Copyright 2001, American Society for Microbiology. All Rights Reserved. JOURNAL OF CLINICAL MICROBIOLOGY, Jan. 2001, p. 241 250 Vol. 39, No. 1 0095-1137/01/$04.00 0 DOI: 10.1128/JCM.39.1.241 250.2001 Copyright 2001, American Society for Microbiology. All Rights Reserved. Ability

More information

Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals

Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals J Vet Diagn Invest :164 168 (1998) Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals Susannah K. Hubert, Phouc Dinh Nguyen, Robert D. Walker Abstract.

More information

What s new in EUCAST methods?

What s new in EUCAST methods? What s new in EUCAST methods? Derek Brown EUCAST Scientific Secretary Interactive question 1 MIC determination MH-F broth for broth microdilution testing of fastidious microorganisms Gradient MIC tests

More information

EUCAST recommended strains for internal quality control

EUCAST recommended strains for internal quality control EUCAST recommended strains for internal quality control Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus influenzae ATCC 59 ATCC

More information

Use of the National Committee for Clinical Laboratory Standards Guidelines for Disk Diffusion Susceptibility Testing in New York State Laboratories

Use of the National Committee for Clinical Laboratory Standards Guidelines for Disk Diffusion Susceptibility Testing in New York State Laboratories JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 2000, p. 3341 3348 Vol. 38, No. 9 0095-1137/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Use of the National Committee for

More information

2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine

2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine 2012 ANTIBIOGRAM Central Zone Former DTHR Sites Department of Pathology and Laboratory Medicine Medically Relevant Pathogens Based on Gram Morphology Gram-negative Bacilli Lactose Fermenters Non-lactose

More information

56 Clinical and Laboratory Standards Institute. All rights reserved.

56 Clinical and Laboratory Standards Institute. All rights reserved. Table 2C 56 Clinical and Laboratory Standards Institute. All rights reserved. Table 2C. Zone Diameter and Minimal Inhibitory Concentration Breakpoints for Testing Conditions Medium: Inoculum: diffusion:

More information

PROTOCOL for serotyping and antimicrobial susceptibility testing of Salmonella test strains

PROTOCOL for serotyping and antimicrobial susceptibility testing of Salmonella test strains PROTOCOL for serotyping and antimicrobial susceptibility testing of Salmonella test strains 1 INTRODUCTION... 1 2 OBJECTIVES... 2 3 OUTLINE OF THE EQAS 2017... 2 3.1 Shipping, receipt and storage of strains...

More information

against Clinical Isolates of Gram-Positive Bacteria

against Clinical Isolates of Gram-Positive Bacteria ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 993, p. 366-370 Vol. 37, No. 0066-0/93/00366-05$0.00/0 Copyright 993, American Society for Microbiology In Vitro Activity of CP-99,9, a New Fluoroquinolone,

More information

Antimicrobial Susceptibility Testing: Advanced Course

Antimicrobial Susceptibility Testing: Advanced Course Antimicrobial Susceptibility Testing: Advanced Course Cascade Reporting Cascade Reporting I. Selecting Antimicrobial Agents for Testing and Reporting Selection of the most appropriate antimicrobials to

More information

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST Help with moving disc diffusion methods from BSAC to EUCAST This document sets out the main differences between the BSAC and EUCAST disc diffusion methods with specific emphasis on preparation prior to

More information

Intrinsic, implied and default resistance

Intrinsic, implied and default resistance Appendix A Intrinsic, implied and default resistance Magiorakos et al. [1] and CLSI [2] are our primary sources of information on intrinsic resistance. Sanford et al. [3] and Gilbert et al. [4] have been

More information

SUPPLEMENT ARTICLE. S114 CID 2001:32 (Suppl 2) Diekema et al.

SUPPLEMENT ARTICLE. S114 CID 2001:32 (Suppl 2) Diekema et al. SUPPLEMENT ARTICLE Survey of Infections Due to Staphylococcus Species: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States, Canada, Latin America, Europe,

More information

Routine internal quality control as recommended by EUCAST Version 3.1, valid from

Routine internal quality control as recommended by EUCAST Version 3.1, valid from Routine internal quality control as recommended by EUCAST Version.1, valid from 01-01-01 Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus

More information

Quality assurance of antimicrobial susceptibility testing

Quality assurance of antimicrobial susceptibility testing Quality assurance of antimicrobial susceptibility testing Derek Brown Routine quality control Repeated testing of controls in parallel with tests to ensure that the test system is performing reproducibly

More information

EUCAST-and CLSI potency NEO-SENSITABS

EUCAST-and CLSI potency NEO-SENSITABS EUCASTand CLSI potency NEOSENSITABS Neo Sensitabs Page 1 / 6 Document: 6.2.0 Fastidious organisms EUCAST Interpretation zones and MIC breakpoints according to recommendations by the "Comité de l'antibiogramme

More information

Service Delivery and Safety Department World Health Organization, Headquarters

Service Delivery and Safety Department World Health Organization, Headquarters Service Delivery and Safety Department World Health Organization, Headquarters WHO global (laboratory-based) survey on multidrug-resistant organisms (MDROs) in health care PROJECT SUMMARY Given the important

More information

APPENDIX III - DOUBLE DISK TEST FOR ESBL

APPENDIX III - DOUBLE DISK TEST FOR ESBL Policy # MI\ANTI\04\03\v03 Page 1 of 5 Section: Antimicrobial Susceptibility Testing Manual Subject Title: Appendix III - Double Disk Test for ESBL Issued by: LABORATORY MANAGER Original Date: January

More information

Antimicrobial Stewardship Strategy: Antibiograms

Antimicrobial Stewardship Strategy: Antibiograms Antimicrobial Stewardship Strategy: Antibiograms A summary of the cumulative susceptibility of bacterial isolates to formulary antibiotics in a given institution or region. Its main functions are to guide

More information

ORIGINAL ARTICLE. Focus Technologies, Inc., 1 Hilversum, The Netherlands, 2 Herndon, Virginia and 3 Franklin, Tennessee, USA

ORIGINAL ARTICLE. Focus Technologies, Inc., 1 Hilversum, The Netherlands, 2 Herndon, Virginia and 3 Franklin, Tennessee, USA ORIGINAL ARTICLE In vitro susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: a European multicenter study during 2000 2001 M. E. Jones 1, R. S. Blosser-Middleton

More information

Short Report. R Boot. Keywords: Bacteria, antimicrobial susceptibility testing, quality, diagnostic laboratories, proficiency testing

Short Report. R Boot. Keywords: Bacteria, antimicrobial susceptibility testing, quality, diagnostic laboratories, proficiency testing Short Report Frequent major errors in antimicrobial susceptibility testing of bacterial strains distributed under the Deutsches Krebsforschungszentrum Quality Assurance Program R Boot Former Section of

More information

ENTEROCOCCI. April Abbott Deaconess Health System Evansville, IN

ENTEROCOCCI. April Abbott Deaconess Health System Evansville, IN ENTEROCOCCI April Abbott Deaconess Health System Evansville, IN OBJECTIVES Discuss basic antimicrobial susceptibility principles and resistance mechanisms for Enterococcus Describe issues surrounding AST

More information

CAP Laboratory Improvement Programs. Performance Accuracy of Antibacterial and Antifungal Susceptibility Test Methods

CAP Laboratory Improvement Programs. Performance Accuracy of Antibacterial and Antifungal Susceptibility Test Methods CAP Laboratory Improvement Programs Performance Accuracy of Antibacterial and Antifungal usceptibility Test Methods Report From the College of American Pathologists Microbiology urveys Program (001 003)

More information

In vitro activity of telavancin against recent Gram-positive clinical isolates: results of the Prospective European Surveillance Initiative

In vitro activity of telavancin against recent Gram-positive clinical isolates: results of the Prospective European Surveillance Initiative Journal of Antimicrobial Chemotherapy (2008) 62, 116 121 doi:10.1093/jac/dkn124 Advance Access publication 19 April 2008 In vitro activity of telavancin against recent Gram-positive clinical isolates:

More information

THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS

THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS Stefanie Desmet University Hospitals Leuven Laboratory medicine microbiology stefanie.desmet@uzleuven.be

More information

Compliance of manufacturers of AST materials and devices with EUCAST guidelines

Compliance of manufacturers of AST materials and devices with EUCAST guidelines Compliance of manufacturers of AST materials and devices with EUCAST guidelines Data are based on questionnaires to manufacturers of materials and devices for antimicrobial susceptibility testing. The

More information

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC MICRONAUT Detection of Resistance Mechanisms Innovation with Integrity BMD MIC Automated and Customized Susceptibility Testing For detection of resistance mechanisms and specific resistances of clinical

More information

Agent-Resistant Enterococci

Agent-Resistant Enterococci JOURNAL OF CLINICAL MICROBIOLOGY, July 1993, p. 1695-1699 0095-1137/93/071695-05$02.00/0 Copyright 1993, American Society for Microbiology Vol. 31, No. 7 Ability of Clinical Laboratories To Detect Antimicrobial

More information

STAPHYLOCOCCI: KEY AST CHALLENGES

STAPHYLOCOCCI: KEY AST CHALLENGES Romney Humphries, PhD D(ABMM) Section Chief, UCLA Clinical Microbiology Los Angeles CA rhumphries@mednet.ucla.edu STAPHYLOCOCCI: KEY AST CHALLENGES THE CHALLENGES detection of penicillin resistance detection

More information

Streptococcus pneumoniae. Oxacillin 1 µg as screen for beta-lactam resistance

Streptococcus pneumoniae. Oxacillin 1 µg as screen for beta-lactam resistance Streptococcus pneumoniae Oxacillin µg as screen for beta-lactam resistance Version 6. June Streptococcus pneumoniae and zone diameter correlates The following histograms present inhibition zone diameter

More information

Are Clinical Laboratories in California Accurately Reporting Vancomycin-Resistant Enterococci?

Are Clinical Laboratories in California Accurately Reporting Vancomycin-Resistant Enterococci? JOURNAL OF CLINICAL ROBIOLOGY, Oct. 1997, p. 2526 2530 Vol. 35, No. 10 0095-1137/97/$04.00 0 Copyright 1997, American Society for Microbiology Are Clinical Laboratories in California Accurately Reporting

More information

Antimicrobial Resistance Trends in the Province of British Columbia

Antimicrobial Resistance Trends in the Province of British Columbia 655 West 12th Avenue Vancouver, BC V5Z 4R4 Tel 604.707.2443 Fax 604.707.2441 www.bccdc.ca Antimicrobial Resistance Trends in the Province of British Columbia 2013 Prepared by the Do Bugs Need Drugs? Program

More information

Compliance of manufacturers of AST materials and devices with EUCAST guidelines

Compliance of manufacturers of AST materials and devices with EUCAST guidelines Compliance of manufacturers of AST materials and devices with EUCAST guidelines Data are based on questionnaires to manufacturers of materials and devices for antimicrobial susceptibility testing. The

More information

Detection and Quantitation of the Etiologic Agents of Ventilator Associated Pneumonia in Endotracheal Tube Aspirates From Patients in Iran

Detection and Quantitation of the Etiologic Agents of Ventilator Associated Pneumonia in Endotracheal Tube Aspirates From Patients in Iran Letter to the Editor Detection and Quantitation of the Etiologic Agents of Ventilator Associated Pneumonia in Endotracheal Tube Aspirates From Patients in Iran Mohammad Rahbar, PhD; Massoud Hajia, PhD

More information

Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance

Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance evolution of antimicrobial resistance Mechanism of bacterial genetic variability Point mutations may occur in a nucleotide base pair,

More information

Method Preferences and Test Accuracy of Antimicrobial Susceptibility Testing

Method Preferences and Test Accuracy of Antimicrobial Susceptibility Testing Method Preferences and Test Accuracy of Antimicrobial Susceptibility Testing Updates From the College of American Pathologists Microbiology Surveys Program (2000) Ronald N. Jones, MD; for the College of

More information

2016 Antibiotic Susceptibility Report

2016 Antibiotic Susceptibility Report Fairview Northland Medical Center and Elk River, Milaca, Princeton and Zimmerman Clinics 2016 Antibiotic Susceptibility Report GRAM-NEGATIVE ORGANISMS 2016 Gram-Negative Non-Urine The number of isolates

More information

Ability of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens: a survey of Project ICARE laboratories

Ability of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens: a survey of Project ICARE laboratories Diagnostic Microbiology and Infectious Disease 38 (2000) 59 67 Surveillance www.elsevier.com/locate/diagmicrobio Ability of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens:

More information

In Vitro Antimicrobial Activity of CP-99,219, a Novel Azabicyclo-Naphthyridone

In Vitro Antimicrobial Activity of CP-99,219, a Novel Azabicyclo-Naphthyridone ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 993, p. 39-353 0066-0/93/0039-05$0.00/0 Copyright 993, American Society for Microbiology Vol. 37, No. In Vitro Antimicrobial Activity of, a Novel Azabicyclo-Naphthyridone

More information

ANTIMICROBIAL SUSCEPTIBILITY DETECTION OF ELEVATED MICs TO PENICILLINS IN β- HAEMOLYTIC STREPTOCOCCI

ANTIMICROBIAL SUSCEPTIBILITY DETECTION OF ELEVATED MICs TO PENICILLINS IN β- HAEMOLYTIC STREPTOCOCCI HAEMOLYTIC STREPTOCOCCI This specimen was designated as a sample from a skin wound that was to be cultured, identified to species level and susceptibility tested [1-3]. The culture contained a Streptococcus

More information

Evaluation of the BIOGRAM Antimicrobial Susceptibility Test System

Evaluation of the BIOGRAM Antimicrobial Susceptibility Test System JOURNAL OF CLINICAL MICROBIOLOGY, Nov. 1985, p. 793-798 0095-1137/85/110793-06$02.00/0 Copyright 1985, American Society for Microbiology Vol. 22, No. 5 Evaluation of the BIOGRAM Antimicrobial Susceptibility

More information

2015 Antibiotic Susceptibility Report

2015 Antibiotic Susceptibility Report Citrobacter freundii Enterobacter aerogenes Enterobacter cloacae Escherichia coli Haemophilus influenzenza Klebsiella oxytoca Klebsiella pneumoniae Proteus mirabilis Pseudomonas aeruginosa Serratia marcescens

More information

BactiReg3 Event Notes Module Page(s) 4-9 (TUL) Page 1 of 21

BactiReg3 Event Notes Module Page(s) 4-9 (TUL) Page 1 of 21 www.wslhpt.org 2601 Agriculture Drive Madison, WI 53718 (800) 462-5261 (608) 265-1111 2015-BactiR Reg3 Shipment Date: September 14, 2015 Questions or comments should be directed to Amanda Weiss at 800-462-5261

More information

Group b strep and macrodantin

Group b strep and macrodantin Group b strep and macrodantin The Borg System is 100 % Group b strep and macrodantin 12-10-2017 Group B Streptococcus, also known as Streptococcus agalactiae, was once considered a pathogen of only domestic

More information

Antimicrobial Susceptibility Testing: The Basics

Antimicrobial Susceptibility Testing: The Basics Antimicrobial Susceptibility Testing: The Basics Susan E. Sharp, Ph.D., DABMM, FAAM Director, Airport Way Regional Laboratory Director, Regional Microbiology and Molecular Infectious Diseases Laboratories

More information

Key words: Campylobacter, diarrhea, MIC, drug resistance, erythromycin

Key words: Campylobacter, diarrhea, MIC, drug resistance, erythromycin Key words: Campylobacter, diarrhea, MIC, drug resistance, erythromycin Table 1 Detection rate of Campylobacter from stool samples taken from sporadic diarrheic patients Table 2 Detection rates of Campylobacter

More information

Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC

Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC 11/20/2014 1 To describe carbapenem-resistant Enterobacteriaceae. To identify laboratory detection standards for carbapenem-resistant

More information

2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose 2017 Antibiogram Central Zone Alberta Health Services including Red Deer Regional Hospital St. Mary s Hospital, Camrose Introduction This antibiogram is a cumulative report of the antimicrobial susceptibility

More information

There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility

There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility ANTIMICROBIAL SUSCEPTIBILITY TESTING ON MILK SAMPLES Method and guidelines There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility

More information

Volume-7, Issue-2, April-June-2016 Coden IJABFP-CAS-USA Received: 5 th Mar 2016 Revised: 11 th April 2016 Accepted: 13 th April 2016 Research article

Volume-7, Issue-2, April-June-2016 Coden IJABFP-CAS-USA Received: 5 th Mar 2016 Revised: 11 th April 2016 Accepted: 13 th April 2016 Research article Volume-7, Issue-2, April-June-2016 Coden IJABFP-CAS-USA Copyrights@2016 Received: 5 th Mar 2016 Revised: 11 th April 2016 Accepted: 13 th April 2016 Research article A STUDY ON ANTIBIOTIC SUSCEPTIBILITY

More information

Defining Resistance and Susceptibility: What S, I, and R Mean to You

Defining Resistance and Susceptibility: What S, I, and R Mean to You Defining Resistance and Susceptibility: What S, I, and R Mean to You Michael D. Apley, DVM, PhD, DACVCP Department of Clinical Sciences College of Veterinary Medicine Kansas State University Susceptible

More information

Protocol for Surveillance of Antimicrobial Resistance in Urinary Isolates in Scotland

Protocol for Surveillance of Antimicrobial Resistance in Urinary Isolates in Scotland Protocol for Surveillance of Antimicrobial Resistance in Urinary Isolates in Scotland Version 1.0 23 December 2011 General enquiries and contact details This is the first version (1.0) of the Protocol

More information

Surveillance for Antimicrobial Resistance and Preparation of an Enhanced Antibiogram at the Local Level. janet hindler

Surveillance for Antimicrobial Resistance and Preparation of an Enhanced Antibiogram at the Local Level. janet hindler Surveillance for Antimicrobial Resistance and Preparation of an Enhanced Antibiogram at the Local Level janet hindler At the conclusion of this talk, you will be able to Describe CLSI M39-A3 recommendations

More information

Concise Antibiogram Toolkit Background

Concise Antibiogram Toolkit Background Background This toolkit is designed to guide nursing homes in creating their own antibiograms, an important tool for guiding empiric antimicrobial therapy. Information about antibiograms and instructions

More information

Main objectives of the EURL EQAS s

Main objectives of the EURL EQAS s EQAS Enterococci, Staphylococci and E. coli EURL workshop, April, 11 Lourdes García Migura Main objectives of the EURL EQAS s To improve the comparability of antimicrobial susceptibility testing (AST)

More information

In Vitro Activities of the Novel Cephalosporin LB against Multidrug-Resistant Staphylococci and Streptococci

In Vitro Activities of the Novel Cephalosporin LB against Multidrug-Resistant Staphylococci and Streptococci ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Jan. 2004, p. 53 62 Vol. 48, No. 1 0066-4804/04/$08.00 0 DOI: 10.1128/AAC.48.1.53 62.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved.

More information

Antimicrobial Resistance Strains

Antimicrobial Resistance Strains Antimicrobial Resistance Strains Microbiologics offers a wide range of strains with characterized antimicrobial resistance mechanisms including: Extended-Spectrum β-lactamases (ESBLs) Carbapenamases Vancomycin-Resistant

More information

Over the past several decades, the frequency of. Resistance Patterns Among Nosocomial Pathogens* Trends Over the Past Few Years. Ronald N.

Over the past several decades, the frequency of. Resistance Patterns Among Nosocomial Pathogens* Trends Over the Past Few Years. Ronald N. Resistance Patterns Among Nosocomial Pathogens* Trends Over the Past Few Years Ronald N. Jones, MD Multiple surveillance studies have demonstrated that resistance among prevalent pathogens is increasing

More information

Susceptibility Testing and Resistance Phenotypes Detection in Bacterial Pathogens Using the VITEK 2 System

Susceptibility Testing and Resistance Phenotypes Detection in Bacterial Pathogens Using the VITEK 2 System Polish Journal of Microbiology 2005, Vol. 54, No 4, 311 316 Susceptibility Testing and Resistance Phenotypes Detection in Bacterial Pathogens Using the VITEK 2 System EL BIETA STEFANIUK*, AGNIESZKA MRÓWKA

More information

2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose 2016 Antibiogram Central Zone Alberta Health Services including Red Deer Regional Hospital St. Mary s Hospital, Camrose Introduction This antibiogram is a cumulative report of the antimicrobial susceptibility

More information

Original Article. Suthan Srisangkaew, M.D. Malai Vorachit, D.Sc.

Original Article. Suthan Srisangkaew, M.D. Malai Vorachit, D.Sc. Original Article Vol. 21 No.1 The optimum agent for ESBL screening and confirmatory tests:- Srisangkaew S & Vorachit M. 1 The Optimum Agent for Screening and Confirmatory Tests for Extended-Spectrum Beta-Lactamases

More information

EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING

EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING CHN61: EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING 1.1 Introduction A common mechanism of bacterial resistance to beta-lactam antibiotics is the production

More information

EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update

EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain

More information

Dalbavancin, enterococci, Gram-positive cocci, Latin America, staphylococci, streptococci

Dalbavancin, enterococci, Gram-positive cocci, Latin America, staphylococci, streptococci ORIGINAL ARTICLE 10.1111/j.1469-0691.2004.01051.x Antimicrobial activity of dalbavancin tested against Gram-positive clinical isolates from Latin American medical centres A. C. Gales 1, H. S. Sader 1,2

More information

Practical approach to Antimicrobial susceptibility testing (AST) and quality control

Practical approach to Antimicrobial susceptibility testing (AST) and quality control Practical approach to Antimicrobial susceptibility testing (AST) and quality control A/Professor John Ferguson, Microbiologist & Infectious Diseases Physician, Pathology North, University of Newcastle,

More information

Epidemiology and Microbiology of Surgical Wound Infections

Epidemiology and Microbiology of Surgical Wound Infections JOURNAL OF CLINICAL MICROBIOLOGY, Feb. 2000, p. 918 922 Vol. 38, No. 2 0095-1137/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Epidemiology and Microbiology of Surgical

More information

Antimicrobial Resistance Trends in the Province of British Columbia. August Epidemiology Services British Columbia Centre for Disease Control

Antimicrobial Resistance Trends in the Province of British Columbia. August Epidemiology Services British Columbia Centre for Disease Control Antimicrobial Resistance Trends in the Province of British Columbia August 2008 Epidemiology Services British Columbia Centre for Disease Control 5 Table of Contents Executive Summary...5 Objective...6

More information

INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER

INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER University of Minnesota Health University of Minnesota Medical Center University of Minnesota Masonic Children s Hospital May 2017 Printed herein are

More information

Childrens Hospital Antibiogram for 2012 (Based on data from 2011)

Childrens Hospital Antibiogram for 2012 (Based on data from 2011) Childrens Hospital Antibiogram for 2012 (Based on data from 2011) Prepared by: Department of Clinical Microbiology, Health Sciences Centre For further information contact: Andrew Walkty, MD, FRCPC Medical

More information

Defining Extended Spectrum b-lactamases: Implications of Minimum Inhibitory Concentration- Based Screening Versus Clavulanate Confirmation Testing

Defining Extended Spectrum b-lactamases: Implications of Minimum Inhibitory Concentration- Based Screening Versus Clavulanate Confirmation Testing Infect Dis Ther (2015) 4:513 518 DOI 10.1007/s40121-015-0094-6 BRIEF REPORT Defining Extended Spectrum b-lactamases: Implications of Minimum Inhibitory Concentration- Based Screening Versus Clavulanate

More information

Antibiotic Reference Laboratory, Institute of Environmental Science and Research Limited (ESR); August 2017

Antibiotic Reference Laboratory, Institute of Environmental Science and Research Limited (ESR); August 2017 Antimicrobial susceptibility of Shigella, 2015 and 2016 Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory, Institute of Environmental Science and Research Limited (ESR); August 2017

More information

Received 5 February 2004/Returned for modification 16 March 2004/Accepted 7 April 2004

Received 5 February 2004/Returned for modification 16 March 2004/Accepted 7 April 2004 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 2004, p. 3112 3118 Vol. 48, No. 8 0066-4804/04/$08.00 0 DOI: 10.1128/AAC.48.8.3112 3118.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved.

More information

Antimicrobial Activity of Linezolid Against Gram-Positive Cocci Isolated in Brazil

Antimicrobial Activity of Linezolid Against Gram-Positive Cocci Isolated in Brazil BJID 2001; 5 (August) 171 Antimicrobial Activity of Linezolid Against Gram-Positive Cocci Isolated in Brazil Helio S. Sader, Ana C. Gales and Ronald N. Jones Special Clinical Microbiology Laboratory, Division

More information

CONTAGIOUS COMMENTS Department of Epidemiology

CONTAGIOUS COMMENTS Department of Epidemiology VOLUME XXIII NUMBER 1 July 2008 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell, SM (ASCP), Marti Roe SM (ASCP), Ann-Christine Nyquist MD, MSPH Are the bugs winning? The 2007

More information

RESISTANCE OF STAPHYLOCOCCUS AUREUS TO VANCOMYCIN IN ZARQA, JORDAN

RESISTANCE OF STAPHYLOCOCCUS AUREUS TO VANCOMYCIN IN ZARQA, JORDAN RESISTANCE OF STAPHYLOCOCCUS AUREUS TO VANCOMYCIN IN ZARQA, JORDAN Hussein Azzam Bataineh 1 ABSTRACT Background: Vancomycin has been widely used in the treatment of infections caused by Methicillin-Resistant

More information

TECHNICAL REPORT External quality assessment of laboratory performance European Antimicrobial Resistance Surveillance Network (EARS-Net), 2017

TECHNICAL REPORT External quality assessment of laboratory performance European Antimicrobial Resistance Surveillance Network (EARS-Net), 2017 TECHNICAL REPORT External quality assessment of laboratory performance European Antimicrobial Resistance Surveillance Network (EARS-Net), 2017 www.ecdc.europa.eu ECDC TECHNICAL REPORT External quality

More information

RCH antibiotic susceptibility data

RCH antibiotic susceptibility data RCH antibiotic susceptibility data The following represent RCH antibiotic susceptibility data from 2008. This data is used to inform antibiotic guidelines used at RCH. The data includes all microbiological

More information

Monitoring of antimicrobial resistance in Campylobacter EURL AR activities in framework of the new EU regulation Lina Cavaco

Monitoring of antimicrobial resistance in Campylobacter EURL AR activities in framework of the new EU regulation Lina Cavaco Monitoring of antimicrobial resistance in Campylobacter EURL AR activities in framework of the new EU regulation Lina Cavaco licav@food.dtu.dk 1 DTU Food, Technical University of Denmark Outline EURL-AR

More information

Leveraging the Lab and Microbiology Department to Optimize Stewardship

Leveraging the Lab and Microbiology Department to Optimize Stewardship Leveraging the Lab and Microbiology Department to Optimize Stewardship Presented by: Andrew Martinez MLS(ASCP), MT(AMT), MBA Alaska Native Medical Center Microbiology Supervisor Maniilaq Health Center

More information

Clinical Usefulness of Multi-facility Microbiology Laboratory Database Analysis by WHONET

Clinical Usefulness of Multi-facility Microbiology Laboratory Database Analysis by WHONET Special Articles Journal of General and Family Medicine 2015, vol. 16, no. 3, p. 138 142. Clinical Usefulness of Multi-facility Microbiology Laboratory Database Analysis by WHONET Sachiko Satake, PhD,

More information

Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method.

Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method. Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method. OBJECTIVES 1. Compare the antimicrobial capabilities of different antibiotics. 2. Compare effectiveness of with different types of bacteria.

More information

SAMPLE. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals

SAMPLE. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals VET01 5th Edition Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals This standard covers the current recommended methods for disk diffusion

More information

CONTAGIOUS COMMENTS Department of Epidemiology

CONTAGIOUS COMMENTS Department of Epidemiology VOLUME XXVII NUMBER 6 July 2012 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine B. Dowell SM, MLS (ASCP); Sarah K. Parker, MD; James K. Todd, MD Each year the Children s Hospital Colorado

More information

Principles of Antimicrobial Therapy

Principles of Antimicrobial Therapy Principles of Antimicrobial Therapy Doo Ryeon Chung, MD, PhD Professor of Medicine, Division of Infectious Diseases Director, Infection Control Office SUNGKYUNKWAN UNIVERSITY SCHOOL OF MEDICINE CASE 1

More information

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Antibiotic Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Any substance of natural, synthetic or semisynthetic origin which at low concentrations kills or inhibits the growth of bacteria

More information

EARS Net Report, Quarter

EARS Net Report, Quarter EARS Net Report, Quarter 4 213 March 214 Key Points for 213* Escherichia coli: The proportion of patients with invasive infections caused by E. coli producing extended spectrum β lactamases (ESBLs) increased

More information